Search research articles
Contact Us
Filters
Showing results (1-10 of 31) with videos related to
Page
of 4
Sort By:
Pharmacoeconomics - Open
|
August 3, 2018
Measuring the Benefits of Decision Aids for Economic Evaluation
Thomas Butt
Applied Health Economics and Health Policy
|
September 18, 2016
Health State Utility Values for Age-Related Macular Degeneration: Review and Advice
Thomas Butt, Adnan Tufail, Gary Rubin
Public Health
|
January 5, 2016
Discounting role in cost-effectiveness of HPV vaccination by Starkie Camejo et al. (Public Health Vol 129(7):989-92)
Thomas Butt, Rosybel Drury, Nathalie Largeron
BMJ Open
|
May 7, 2015
The cost-effectiveness of initiating ranibizumab therapy in eyes with neovascular AMD with good vision: an economic model using real-world outcomes
Thomas Butt, Aaron Lee, Cecilia Lee, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
June 15, 2025
Health State Utilities for Achondroplasia: A Time Trade-Off Study
Claudia Mighiu, George Morgan, Rashmi Bharali, et al.
Applied Health Economics and Health Policy
|
March 11, 2014
Modelling cost effectiveness in neovascular age-related macular degeneration: the impact of using contrast sensitivity vs. visual acuity
Thomas Butt, Praveen J Patel, Adnan Tufail, et al.
BMJ Global Health
|
June 11, 2019
Taking stock of cost-effectiveness analysis of healthcare in China
Thomas Butt, Gordon G Liu, David D Kim, et al.
BMC Health Services Research
|
March 19, 2020
The role of mediation in solving medical disputes in China
Mengxiao Wang, Gordon G Liu, Hanqing Zhao, et al.
Health Economics
|
April 28, 2026
How Does the Ethical Environment Matter to Hospital Performance?
Mengxiao Wang, Gordon G Liu, Thomas Butt, et al.
Optometry and Vision Science : Official Publication of the American Academy of Optometry
|
July 2, 2013
Patient and public preferences for health states associated with AMD
Thomas Butt, Hannah M P Dunbar, Stephen Morris, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 31) with videos related to
Sort By:
Page
of 4
Pharmacoeconomics - Open
|
August 3, 2018
Measuring the Benefits of Decision Aids for Economic Evaluation
Thomas Butt
Applied Health Economics and Health Policy
|
September 18, 2016
Health State Utility Values for Age-Related Macular Degeneration: Review and Advice
Thomas Butt, Adnan Tufail, Gary Rubin
Public Health
|
January 5, 2016
Discounting role in cost-effectiveness of HPV vaccination by Starkie Camejo et al. (Public Health Vol 129(7):989-92)
Thomas Butt, Rosybel Drury, Nathalie Largeron
BMJ Open
|
May 7, 2015
The cost-effectiveness of initiating ranibizumab therapy in eyes with neovascular AMD with good vision: an economic model using real-world outcomes
Thomas Butt, Aaron Lee, Cecilia Lee, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
June 15, 2025
Health State Utilities for Achondroplasia: A Time Trade-Off Study
Claudia Mighiu, George Morgan, Rashmi Bharali, et al.
Applied Health Economics and Health Policy
|
March 11, 2014
Modelling cost effectiveness in neovascular age-related macular degeneration: the impact of using contrast sensitivity vs. visual acuity
Thomas Butt, Praveen J Patel, Adnan Tufail, et al.
BMJ Global Health
|
June 11, 2019
Taking stock of cost-effectiveness analysis of healthcare in China
Thomas Butt, Gordon G Liu, David D Kim, et al.
BMC Health Services Research
|
March 19, 2020
The role of mediation in solving medical disputes in China
Mengxiao Wang, Gordon G Liu, Hanqing Zhao, et al.
Health Economics
|
April 28, 2026
How Does the Ethical Environment Matter to Hospital Performance?
Mengxiao Wang, Gordon G Liu, Thomas Butt, et al.
Optometry and Vision Science : Official Publication of the American Academy of Optometry
|
July 2, 2013
Patient and public preferences for health states associated with AMD
Thomas Butt, Hannah M P Dunbar, Stephen Morris, et al.
Page
of 4